|

Asthma Clinical Trials in Baltimore, MD

25 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
Metformin IN Asthma for Overweight and Obese Individuals (MINA)Phase 2<1 mi
Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)N/A<1 mi
Y of Central Maryland Head Start Asthma Implementation—6 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 36 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 310 mi
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects—10 mi
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaPhase 412 mi
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPhase 312 mi
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaPhase 212 mi
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)Phase 212 mi
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)Phase 212 mi
A Study to Evaluate Solriktug in Adult Participants With AsthmaPhase 212 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 212 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 324 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaPhase 230 mi
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia—34 mi
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up—34 mi
Role of Genetic Factors in the Development of Lung Disease—34 mi
Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma CareN/A36 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)—36 mi
The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma ClinicN/A36 mi
Omalizumab Before Onset of ExacerbationsPhase 236 mi
Protocol CAUSE-03 / CHEETAH—36 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaPhase 441 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.